Trials / Unknown
UnknownNCT02467647
The Effects of Huang-Lian-Jie-Du-Tang（HLJDT) on the Survival of Patients With Multiple Myeloma in Maintain Therapy
Phase 1 Study of the Effects of Huang-Lian-Jie-Du-Tang（HLJDT) on the Survival of Patients With Multiple Myeloma in Maintain Therapy
- Status
- Unknown
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 500 (estimated)
- Sponsor
- Wuhan University · Academic / Other
- Sex
- All
- Age
- 20 Years – 85 Years
- Healthy volunteers
- Not accepted
Summary
To investigate the efficacy of the combination of Thalidomide and Huang-Lian-Jie-Du-Tang on the patients with multiple myeloma in maintain therapy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Thalidomide | |
| DRUG | HLJDT |
Timeline
- Start date
- 2015-01-01
- Primary completion
- 2018-12-01
- Completion
- 2019-12-01
- First posted
- 2015-06-10
- Last updated
- 2015-06-10
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT02467647. Inclusion in this directory is not an endorsement.